Skip to main content

Companies implementing Model-Informed Drug Development (MIDD)

Model-informed drug development (MIDD) employs quantitative modeling techniques throughout the drug development lifecycle to support decisions such as dose selection, efficacy justification, trial design, and policy guidance.

List of companies that implement Model-Informed Drug Development (MIDD)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United Kingdom

Pharmaceutical Manufacturing

98k

$35B

Model-Informed Drug Development (MIDD)

United States

Pharmaceutical Manufacturing

39k

$46B

Model-Informed Drug Development (MIDD)

United States

Pharmaceutical Manufacturing

108k

$100B

Model-Informed Drug Development (MIDD)

United States

Biotechnology Research

15k

$27B

Model-Informed Drug Development (MIDD)

United States

Pharmaceutical Manufacturing

58k

$29B

Model-Informed Drug Development (MIDD)

United States

Biotechnology Research

21k

$26B

Model-Informed Drug Development (MIDD)

United States

Pharmaceutical Manufacturing

43k

Model-Informed Drug Development (MIDD)

Japan

Pharmaceutical Manufacturing

37k

$31B

Model-Informed Drug Development (MIDD)

United States

Biotechnology Research

9.2k

$10B

Model-Informed Drug Development (MIDD)

United States

Pharmaceutical Manufacturing

1.9k

Model-Informed Drug Development (MIDD)

Showing top companies out of 426 that implement Model-Informed Drug Development (MIDD). Get the full list on TheirStack.

Frequently asked questions